antipsychotic medication in the year were investigated for the prescribed medication and concomitant psychotropic medication. Results: A total of 91 children and adolescents (mean age 16.2 ± 2.2 years, 53 boys) received antipsychotic medication. Among the prescriptions, risperidone (n = 59, 35.3%) and aripiprazole (n = 34, 20.4%) were the two most frequently prescribed antipsychotics. Of 91 patients, 80 (87.9%) have prescribed with antipsychotic monopharmacy (mean 134.9 ± 11.1 day), 33 (36.3%) with bipharmacy (mean 136.9 ± 20.2 days), and 12 (13.2%) with polypharmacy (more than three antipsychotics) (mean 32.5 ± 7.3 days) in the year. Mood stabilizers (n=48, 52.7%), and antidepressants (n=35, 38.5%) were co-medicated in the year. Discussion: Our study shows the prescription pattern of antipsychotics for children and adolescents with schizophrenia in Korea. 
F36. SELF-ESTEEM AND SYMPTOMS IN INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS

Columbia University
Background: Individuals with psychotic symptoms often report low global self-esteem (GSE). However, it remains unclear whether the low GSE is linked to the presence of psychotic symptoms or it is present prior to the onset of psychosis. Additionally, the specific subdomains of GSE in these populations are unknown.
Methods:
To address this question, we conducted a cross-sectional study comparing global and SE elements among individuals at clinical high-risk for psychosis (CHR; n=36), individuals with schizophrenia (SCZ; n=43), and healthy controls (HC; n=40). We then examined among CHR individuals the association between GSE, subdomains, and symptoms. Results: CHR individuals displayed significantly lower GSE compared to HC, at a level comparable to individuals with SCZ. The low GSE was driven primarily by self-perceptions of work and interpersonal relationships abilities, in the sub-domains of provider (r=.53, p<.001), physical appearance (r=.37, p=.026), sense of humor (r=.45, p=.006), intimate relations (r=.45, p=.006), and job competence (r=.39, p=.018). Lower GSE was associated with overall negative (p<0.01) and disorganized (p<0.05) symptoms severity, but not positive ones. Discussion: This investigation demonstrates that low self-esteem, which is prevalent in SCZ, is also present to a comparable degree of severity in CHR individuals. Our findings help to better understand the CHR period and may suggest targets for early psychosocial treatments aimed at improving social and occupational functioning, as such domains appear to play an important role in determining GSE in this population. The examination of different dimensions of self-esteem in the assessment of CHR populations may contribute to a better understanding of the phenomenology of prodromal symptoms, and thus, may have implications for finding successful early therapeutic approaches, rehabilitation, and social integration for a condition that is accompanied by considerable suffering and risk of suicide. In addition, Cav-KHypo mice show schizophrenia-relevant alterations in cerebral metabolism including prefrontal cortex, thalamic and hippocampal hypometabolism. The induction of Cav1.2 hypofunction in ketamine activated brain networks impairs memory consolidation by altering functional connectivity between neural systems underlying this process, including compromised prefrontal-hippocampal and compromised thalamic connectivity. Discussion: The data suggest that reducing CACNA1C expression in brain areas linked to schizophrenia is sufficient to induce disease related neural dysfunction. Furthermore, the data suggest that the regulation of neural system functional connectivity and memory consolidation may be primary mechanisms through which CACNA1C risk genes impact on cognition and increases the risk of developing psychiatric disorders. Background: Patients with schizophrenia exhibit negative symptoms that predict functional outcome. Understanding the mechanisms underlying these symptoms are important for developing novel therapeutic treatments. These negative symptoms can be grouped into experiential-(motivational) or expressive-(social) based behaviors testable in rodents. Increased incidences of schizophrenia have been reported with winter gestation, while antagonizing NMDA receptor function in adulthood has been used to model other symptoms of schizophrenia. These two approaches were used to determine mechanisms that may contribute to negative symptoms in schizophrenia and test potential therapeutics. Methods: Normal dam mice were housed in custom photoperiod chambers for one week under normal photoperiod conditions (12 hour light:12 hour dark) to allow for initial acclimation. Half of the photoperiod chambers were then shifted to a short active (SA) condition (19 hours light: 5 hours dark) with mating triads formed. After a two-week pairing, pregnant dams were single-housed. The resulting pups were reared under these photoperiod conditions until P28, at which time they were weaned by sex into tetrads and moved into a standard vivarium room under normal active (NA) photoperiod. Mice were trained to perform nose-poke responses in a five-choice operant chamber. Adult Long Evans rats were also trained in separate 5-choice chambers and repeatedly treated with phencyclidine (PCP). Motivational behavior was tested on a progressive ratio breakpoint (PRB). Social behavior of mice were also assessed using a 3-chocie social recognition paradigm. Results: In PRB, breakpoint was decreased in WT mice reared in SA vs. NA photoperiod (F(1,66)=4.4, p<0.05). In contrast however, no deficits in social interaction was observed (F<1, ns 
F37. CACNA1C HYPOFUNCTION IN KETAMINE-ACTIVATED BRAIN NETWORKS IMPAIRS
F38. WINTER-LIKE PHOTOPERIOD GESTATION DELETERIOUSLY AFFECT EXPERIENTIAL-BUT NOT EXPRESSIVE-RELATED BEHAVIORS, WHILE ADULT PHENCYCLIDINE TREATMENT INCREASES EXPERIENTIAL BEHAVIORS
